Editorial Commentary
New functions assigned to a microRNA with genetic links to prostate cancer risk
Abstract
Germline genetic analyses have begun to identify links between microRNA (miRNA) binding sites and the heritable risk of developing prostate cancer (PCa). Interestingly, one of the most significant links involves the diagnostic biomarker, PSA.